Peregrine Pharmaceuticals (PPHM) Goes Red to Green
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Join SI Premium – FREE
After trading lower earlier, Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) jumped into positive territory. Shares are now up 1 percent.
We are hearing this is related to positive commentary on today's Wedbush conference. Sources on the call said it's going "great."
Earlier, Roth Capital added the stock it to its Focus List.
Shares are up 350 percent since the end of June, mainly on the hopes for cancer drug bavituximab.
We are hearing this is related to positive commentary on today's Wedbush conference. Sources on the call said it's going "great."
Earlier, Roth Capital added the stock it to its Focus List.
Shares are up 350 percent since the end of June, mainly on the hopes for cancer drug bavituximab.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hunterbrook Capital is short bonds issued by Sammons Financial Group and short Guggenheim Strategic Opportunities Fund
- SpaceX's Musk: My best guess for ~$3.5T revenue is roughly around 2033
- YouTube Probed By FTC Over Blocked Social Media Accounts - Bloomberg
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
